Luke M. Tomasovic

Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection

Mark S. Anderson, Jamie B. Spangler, Aaron S. Meyer, 2022, bioRxiv.

Empowering gene delivery with protein engineering platforms.

Jamie B. Spangler, Luke M. Tomasovic, M. Kizerwetter, 2022, Gene therapy.

Lung tumor-infiltrating Treg have divergent transcriptional profiles and function linked to checkpoint blockade response

Jamie B. Spangler, J. Taube, Hongkai Ji, 2022, bioRxiv.

Stain-resistant, superomniphobic flexible optical plastics based on nano-enoki mushroom-like structures

Paul W. Leu, D. Pekker, Sajad Haghanifar, 2019, Journal of Materials Chemistry A.

IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern

R. Baric, W. Marasco, E. Saphire, 2022, Nature Communications.

Engineering active lysostaphin variants that incorporate noncanonical amino acids and characterizing the effects of site‐specific PEGylation

Andrés J. García, R. Kane, S. Satola, 2023, Biotechnology and bioengineering.

Designed Endocytosis-Triggering Proteins mediate Targeted Degradation

Craig L. Dobbins, Jamie B. Spangler, Kole T. Roybal, 2023, bioRxiv.

Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases.

Jamie B. Spangler, D. VanDyke, Luke M. Tomasovic, 2023, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.